First US immunizations could arrive Dec. 12, chief of Operation Warp Speed says
A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.
Share:
More Stories
Hometown Heroes in New York City
2ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
317ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
331ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
332ds agoHometown Heroes in New York City
2ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
317ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
331ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
332ds ago
The head of the U.S. effort to produce a coronavirus vaccine says the first immunizations could happen on Dec. 12.
A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.
MORE COVERAGE: Pfizer is asking for emergency use of its COVID-19 vaccine; What happens next? 5 things you need to know
Pfizer and its German partner BioNTech recently announced that the vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Dr. Moncef Slaoui, head of the Operation Warp Speed, the coronavirus vaccine program, says plans are to ship vaccines to states within 24 hours of expected FDA approval.
Slaoui told CNN he expects vaccinations would begin on the second day after approval, Dec. 12
